Journal article
Functional upregulation of system xc− by fibroblast growth factor-2
Neuropharmacology, Vol.62(2), pp.901-906
2012
DOI: 10.1016/j.neuropharm.2011.09.019
PMID: 21967732
Abstract
The cystine/glutamate antiporter (system xc−) is a Na
+-independent amino acid transport system. Disruption of this system may lead to multiple effects in the CNS including decreased cellular glutathione. Since multiple neurological diseases involve glutathione depletion, and disruption of growth factor signaling has also been implicated in these diseases, it is possible that some growth factors effects are mediated by regulation of system xc−. We tested the growth factors fibroblast growth factor-2 (FGF-2), insulin-like growth factor-1 (IGF-1), neuregulin-1 (NRG), neurotrophin-4 (NT-4), and brain derived neurotrophic factor (BDNF) on system xc− mediated 14C-cystine uptake in mixed neuronal and glial cortical cultures. Only FGF-2 significantly increased cystine uptake. The effect was observed in astrocyte-enriched cultures, but not in cultures of neurons or microglia. The increase was blocked by the system xc− inhibitor (s)-4-carboxyphenylglycine, required at least 12 h FGF-2 treatment, and was prevented by the protein synthesis inhibitor cycloheximide. Kinetic analysis indicated FGF-2 treatment increased the
V
max for cystine uptake while the
K
m remained the same. Quantitative PCR showed an increase in mRNA for xCT, the functional subunit of system xc−, beginning at 3 h of FGF-2 treatment, with a dramatic increase after 12 h. Blocking FGFR1 with PD 166866 blocked the FGF-2 effect. Treatment with a PI3-kinase inhibitor (LY-294002) or a MEK/ERK inhibitor (U0126) for 1 h prior to and during the FGF-2 treatment, each partially blocked the increased cystine uptake. The upregulation of system xc− by FGF-2 may be responsible for some of the known physiological actions of FGF-2.
This article is part of a Special Issue entitled ‘Post-Traumatic Stress Disorder’.
► System xc− regulates cellular glutathione and extracellular glutamate levels. ► FGF-2 causes a functional upregulation of system xc− activity. ► Upregulation of system xc− may account for many physiological actions of FGF-2.
Details
- Title: Subtitle
- Functional upregulation of system xc− by fibroblast growth factor-2
- Creators
- XiaoQian LiuJon ReschTravis RushDoug Lobner
- Resource Type
- Journal article
- Publication Details
- Neuropharmacology, Vol.62(2), pp.901-906
- Publisher
- Elsevier Ltd
- DOI
- 10.1016/j.neuropharm.2011.09.019
- PMID
- 21967732
- ISSN
- 0028-3908
- eISSN
- 1873-7064
- Language
- English
- Date published
- 2012
- Academic Unit
- Iowa Neuroscience Institute; Fraternal Order of Eagles Diabetes Research Center; Neuroscience and Pharmacology
- Record Identifier
- 9984065749702771
Metrics
15 Record Views